Hayata, N.; Hosui, A.; Kurahashi, T.; Suemura, S.; Namiki, A.; Okamoto, A.; Tanimoto, T.; Murai, H.; Ohnishi, K.; Hirao, M.;
et al. Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma. Cancers 2025, 17, 2971.
https://doi.org/10.3390/cancers17182971
AMA Style
Hayata N, Hosui A, Kurahashi T, Suemura S, Namiki A, Okamoto A, Tanimoto T, Murai H, Ohnishi K, Hirao M,
et al. Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma. Cancers. 2025; 17(18):2971.
https://doi.org/10.3390/cancers17182971
Chicago/Turabian Style
Hayata, Naoko, Atsushi Hosui, Tomohide Kurahashi, Shigeki Suemura, Akane Namiki, Akino Okamoto, Takafumi Tanimoto, Hiroki Murai, Kohsaku Ohnishi, Motohiro Hirao,
and et al. 2025. "Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma" Cancers 17, no. 18: 2971.
https://doi.org/10.3390/cancers17182971
APA Style
Hayata, N., Hosui, A., Kurahashi, T., Suemura, S., Namiki, A., Okamoto, A., Tanimoto, T., Murai, H., Ohnishi, K., Hirao, M., Yamada, T., & Hiramatsu, N.
(2025). Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma. Cancers, 17(18), 2971.
https://doi.org/10.3390/cancers17182971
